We are grateful for rapid funding from Fast Grants and Emergent Ventures, which will enable the lab to study the cellular and molecular basis of durable immunity to SARS-CoV-2.

Fast Grants (https://fastgrants.org)
Emergent Ventures (https://www.mercatus.org/emergent-ventures)